Abdul Mannan Baig

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 39

Top Venues

ACS chemical neuroscience

Reviews in medical virology

CNS neuroscience & therapeutics

Journal of medical virology

Aga Khan University Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Aga Khan University Hospital Feb 14 2012

Pakistan

Senior Researcher :: Biological and Biomedical Sciences

Publications

Abdul Mannan Baig, Sandy Rosko, Beate Jaeger, Joachim Gerlach, Hans Rausch
Unraveling the enigma of long COVID: novel aspects in pathogenesis, diagnosis, and treatment protocols. Inflammopharmacology 32 (4) (2024)
Abdul Mannan Baig, Sandy Rosko, Beate Jaeger, Joachim Gerlach, Hans Rausch
Unraveling the enigma of long COVID: novel aspects in pathogenesis, diagnosis, and treatment protocols. Inflammopharmacology (2024)
Abdul Mannan Baig, Joachim Gerlach
Intranasal Route: A Nasocerebral Approach against SARS-CoV-2 in NeuroCOVID. ACS chemical neuroscience (2023)
Joachim Gerlach, Abdul Mannan Baig, Mark Fabrowski, Valentina Viduto
The immune paradox of SARS-CoV-2: Lymphocytopenia and autoimmunity evoking features in COVID-19 and possible treatment modalities. Reviews in medical virology (2023)
Joachim Gerlach, Abdul Mannan Baig, Mark Fabrowski, Valentina Viduto
The immune paradox of SARS-CoV-2: Lymphocytopenia and autoimmunity evoking features in COVID-19 and possible treatment modalities. Reviews in medical virology 33 (2) (2023)
Joachim Gerlach, Abdul Mannan Baig, Mark Fabrowski, Valentina Viduto
The immune paradox of SARS-CoV-2: Lymphocytopenia and autoimmunity evoking features in COVID-19 and possible treatment modalities. Reviews in medical virology 33 (2) (2023)
Joachim Gerlach, Abdul Mannan Baig, Mark Fabrowski, Valentina Viduto
The immune paradox of SARS-CoV-2: Lymphocytopenia and autoimmunity evoking features in COVID-19 and possible treatment modalities. Reviews in medical virology 33 (2) (2023)
Abdul Mannan Baig
Correlating Biochemical and Structural Changes in the Brain with Clinical Features in COVID-19. ACS chemical neuroscience 13 (8) (2022)
Abdul Mannan Baig
Differential diagnosis and pathogenesis of the neurological signs and symptoms in COVID-19 and long-COVID syndrome. CNS neuroscience & therapeutics 28 (12) (2022)
Abdul Mannan Baig, Nigel H Greig, Joachim Gerlach, Prakash Salunke, Mark Fabrowski, Valentina Viduto, Tazeen Ali
Underlying Causes and Treatment Modalities for Neurological Deficits in COVID-19 and Long-COVID. ACS chemical neuroscience 13 (20) (2022)
Abdul Mannan Baig
Chronic COVID syndrome: Need for an appropriate medical terminology for long-COVID and COVID long-haulers. Journal of medical virology 93 (5) (2021)
Dennis C Liotta, Abdul Mannan Baig
NeuroChat with Dr. Abdul Mannan Baig. ACS chemical neuroscience 11 (20) (2021)
Abdul Mannan Baig
Pathways and Pathogenesis of Hearing Deficits, Tinnitus, and Vertigo in COVID-19. ACS chemical neuroscience 12 (23) (2021)
Abdul Mannan Baig
Chronic long-COVID syndrome: A protracted COVID-19 illness with neurological dysfunctions. CNS neuroscience & therapeutics 27 (12) (2021)
Abdul Mannan Baig
Targeting Neuroinvasion by SARS-CoV-2: Emerging Trends in Drug and Antibody Delivery to Combat COVID-19. ACS chemical neuroscience 12 (14) (2021)
Abdul Mannan Baig
Counting the neurological cost of COVID-19. Nature reviews. Neurology (2021)
Abdul Mannan Baig
Deleterious Outcomes in Long-Hauler COVID-19: The Effects of SARS-CoV-2 on the CNS in Chronic COVID Syndrome. ACS chemical neuroscience 11 (24) (2020)
Abdul Mannan Baig
Can Neurotropic Free-Living Amoeba Serve as a Model to Study SARS-CoV-2 Pathogenesis? ACS chemical neuroscience 11 (22) (2020)
Abdul Mannan Baig, Erin C Sanders
Heralding Healthcare Professionals: Recognition of Neurological Deficits in COVID-19. ACS chemical neuroscience 11 (12) (2020)
Abdul Mannan Baig
Neurological manifestations in COVID-19 caused by SARS-CoV-2. CNS neuroscience & therapeutics 26 (5) (2020)
Abdul Mannan Baig, Erin C Sanders
Potential neuroinvasive pathways of SARS-CoV-2: Deciphering the spectrum of neurological deficit seen in coronavirus disease-2019 (COVID-19). Journal of medical virology 92 (10) (2020)
Abdul Mannan Baig
Covert Pathways to the Cranial Cavity: Could These Be Potential Routes of SARS-CoV-2 to the Brain? ACS chemical neuroscience 11 (20) (2020)
Abdul Mannan Baig, Naveed Ahmed Khan, Preet Katyara, Salima Lalani, Rozeena Baig, Mehdia Nadeem, Noor Akbar, Fizza Nazim, Areeba Khaleeq
'Targeting the feast of a sleeping beast': Nutrient and mineral dependencies of encysted Acanthamoeba castellanii. Chemical biology & drug design 97 (1) (2020)
Abdul Mannan Baig, Areeba Khaleeq, Hira Syeda
Elucidation of cellular targets and exploitation of the receptor-binding domain of SARS-CoV-2 for vaccine and monoclonal antibody synthesis. Journal of medical virology 92 (11) (2020)
Abdul Mannan Baig, Areeba Khaleeq, Usman Ali, Hira Syeda
Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS chemical neuroscience 11 (7) (2020)
Abdul Mannan Baig
Computing the Effects of SARS-CoV-2 on Respiration Regulatory Mechanisms in COVID-19. ACS chemical neuroscience 11 (16) (2020)
Abdul Mannan Baig, Zohaib Rana, Nuzair Waliani, Saiqa Karim, Mehdia Rajabali
Evidence of human-like Ca2+ channels and effects of Ca2+ channel blockers in Acanthamoeba castellanii. Chemical biology & drug design 93 (3) (2019)
Abdul Mannan Baig, Preet Katyara, Areeba Khaleeq, Fizza Nazim
Repurposing drugs: Ca2+ ion dependency that can be exploited to treat keratitis caused by Acanthamoeba castellanii. Eye (London, England) 33 (11) (2019)
Abdul Mannan Baig, Areeba Khaleeq, Fizza Nazim
Targeting CNS Related Protist Pathogens: Calcium Ion Dependency in the Brain-Eating Amoebae. ACS chemical neuroscience 11 (16) (2019)
Abdul Mannan Baig, Preet Katyara, Mehdia Nadeem Rajabali, Areeba Khaleeq, Fizza Nazim, Salima Lalani
Neuroleptic Drug Targets a Brain-Eating Amoeba: Effects of Promethazine on Neurotropic Acanthamoeba castellanii. ACS chemical neuroscience 10 (6) (2019)
Abdul Mannan Baig
Torn from the headlines: role of public awareness and bench- to-bedside research in prevention and treatment of Acanthamoeba keratitis. Eye (London, England) 33 (5) (2018)
Abdul Mannan Baig
Drug targeting in Acanthamoeba keratitis: rational of using drugs that are already approved for ocular use in non-keratitis indications. Eye (London, England) 33 (3) (2018)
Abdul Mannan Baig
Connecting the Dots: Linking the Biochemical to Morphological Transitions in Alzheimer's Disease. ACS chemical neuroscience 10 (1) (2018)
Abdul Mannan Baig
DARK Side of Amphetamine and Analogues: Pharmacology, Syndromic Manifestation, and Management of Amphetamine Addiction. ACS chemical neuroscience 9 (10) (2018)
Abdul Mannan Baig
Human Genome-Edited Babies: First Responder with Concerns Regarding Possible Neurological Deficits! ACS chemical neuroscience 10 (1) (2018)
Abdul Mannan Baig
Is There a Cholinergic Survival Incentive for Neurotropic Parasites in the Brain? ACS chemical neuroscience 8 (12) (2017)
Abdul Mannan Baig, Zohaib Rana, Sumayya Tariq, Salima Lalani, H R Ahmad
Traced on the Timeline: Discovery of Acetylcholine and the Components of the Human Cholinergic System in a Primitive Unicellular Eukaryote Acanthamoeba spp. ACS chemical neuroscience 9 (3) (2017)
Abdul Mannan Baig
Emerging Insights for Better Delivery of Chemicals and Stem Cells to the Brain. ACS chemical neuroscience 8 (6) (2017)
Abdul Mannan Baig, Nuzair Waliani, Saiqa Karim
Drug Target Discovery Methods In Targeting Neurotropic Parasitic Amoebae. ACS chemical neuroscience 9 (2) (2017)

Abdul Mannan Baig.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Abdul Mannan Baig